Needle-Free CGM Could Be Available in 2013

Diabetes Health Staff

Sep 26, 2012

Philadelphia-based Echo Therapeutics plans to introduce a needle-free continuous glucose monitoring system to the US market in 2013, pending FDA approval. The Symphony® tCGM is a two-part device that monitors blood glucose by taking readings through a user’s skin rather than via finger pricks. It is intended for use by anyone with diabetes, not just insulin pump users.

The unit’s first component is the Prelude® skin permeation system, which removes the patient’s outermost layer of dead skin cells where the biosensor is to be attached. According to Echo, the device takes three to eight seconds to painlessly remove the skin, leaving an abrasion that is not visible to the naked eye. The rechargeable Prelude will require a new tip after each use, which the company says will cost only pennies.

The patient then attaches the Symphony biosensor, which monitors blood sugar levels every minute, to the cleared skin area. Echo recommends that the Symphony biosensor be placed on one spot for a maximum of three days before being relocated to another spot. The company says that this practice will virtually eliminate the skin irritation that many CGM users encounter.

The Symphony will use wireless technology to send minute-by-minute readings to such remote monitors as smartphones, computers, or tablets. When a patient’s glucose level reaches a number outside the target range, an audible alarm and visual graphics will sound the alert.

Echo says that in clinical trials of the Symphony, 94.4 percent of the system’s readings were clinically accurate, with a further 2.5 percent defined as “benign errors.” The overall accuracy of the Symphony’s readings was rated at 96.9 percent. When compared to readings provided by a controlled reference, 96.8 percent of Symphony’s minute-by-minute readings varied by plus or minus two mg/dL.

This YouTube video shows how the unit works.

Categories: Blood Sugar, Diabetes, Diabetes Health, Diabetes Health Magazine, Diabetic, FDA, Healthy Lifestyle, Insulin Pump, Research

Comments

Add your comments about this article below. You can add comments as a registered user or anonymously. If you choose to post anonymously your comments will be sent to our moderator for approval before they appear on this page. If you choose to post as a registered user your comments will appear instantly.

When voicing your views via the comment feature, please respect the Diabetes Health community by refraining from comments that could be considered offensive to other people. Diabetes Health reserves the right to remove comments when necessary to maintain the cordial voice of the diabetes community.

For your privacy and protection, we ask that you do not include personal details such as address or telephone number in any comments posted.

Don't have your Diabetes Health Username? Register now and add your comments to all our content.

Have Your Say...

Registered User Anonymous

Your Name:	Your Email:	X

Recipient's Name:	Recipient's Email:

Your Chosen Username:	Your Email Address:

Chosen Password:	Confirm Password:

Email to a Friend

Needle-Free CGM Could Be Available in 2013

You May Also Be Interested In...

Comments

Register...

Have Your Say...

Diabetes Health

Topics

Topics

Topics

Diabetes Health Medical Disclaimer

Comment: